These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 4139757)
21. [Immunological interrelationships of the body and the tumor]. Govallo VI Vopr Onkol; 1975; 21(10):93-102. PubMed ID: 52944 [No Abstract] [Full Text] [Related]
22. T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity. Wagner H; Röllinghoff M; Nossal GJ Transplant Rev; 1973; 17(0):3-36. PubMed ID: 4151904 [No Abstract] [Full Text] [Related]
23. Immunity in leukemia. Gatti RA Boll Ist Sieroter Milan; 1974; 53(1):suppl:275-81. PubMed ID: 4277522 [No Abstract] [Full Text] [Related]
28. [Cellular and genetic aspects of antibody formation (author's transl)]. Sado T Tanpakushitsu Kakusan Koso; 1975 Jul; 20(9):833-43. PubMed ID: 1103236 [No Abstract] [Full Text] [Related]
29. In vitro-demonstration of cellular hypersensitivity to tumour antigens in man. Andersen V; Kjaer M; Bendixen G Ser Haematol; 1972; 5(5):3-21. PubMed ID: 4598039 [No Abstract] [Full Text] [Related]
30. [Current problems in immunology]. Ambrosius H Z Gesamte Inn Med; 1974 Apr; 29(8):309-15. PubMed ID: 4137395 [No Abstract] [Full Text] [Related]
31. Delayed cutaneous hypersensitivity reactions to extracts of human tumors. Herberman RB; Hollinshead AC; Alford TC; McCoy JL; Halterman RH; Leventhal BG Natl Cancer Inst Monogr; 1973 Jun; 37():189-95. PubMed ID: 4123453 [No Abstract] [Full Text] [Related]
32. The effects of proteolysis on the human immune mechanism in cancer. A preliminary communication. Thornes RD; Smyth H; Browne O; O'Gorman M; Reen DJ; Farrell D; Holland PD J Med; 1974; 5(1):92-7. PubMed ID: 4275505 [No Abstract] [Full Text] [Related]
33. Mechanisms of allograft rejection. Hamburger J Trans Am Soc Artif Intern Organs; 1976; 22():729-33. PubMed ID: 781987 [No Abstract] [Full Text] [Related]
34. The role of cellular immunity in neoplasia. Glade PR; Zaldivar NM; Mayer L; Cahill LT Pediatr Res; 1976 May; 10(5):517-22. PubMed ID: 778771 [No Abstract] [Full Text] [Related]
35. Cell-mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen--relationship to immunocompetence and prognosis. Gutterman JU; Hersh EM; Mavligit GM; Freireich EJ; Rossen RD; Butler WT; McCredie KB; Bodey GP; Rodriguez V Natl Cancer Inst Monogr; 1973 Jun; 37():153-65. PubMed ID: 4576706 [No Abstract] [Full Text] [Related]
36. [Lymphocytes. Roles in cellular immunity and humoral immunity]. Golovtchenko AM; Raichvarg D Ann Biol Clin (Paris); 1975; 33(2):63-74. PubMed ID: 1080972 [TBL] [Abstract][Full Text] [Related]
37. Studies on a gross-virus-induced lymphoma in the rat. I. The cell-mediated immune response. Shellam GR Int J Cancer; 1974 Jul; 14(1):65-82. PubMed ID: 4376509 [No Abstract] [Full Text] [Related]
39. Human leukemia antigen. I. Production and characterization of antisera. Billing R; Terasaki PI J Natl Cancer Inst; 1974 Dec; 53(6):1635-8. PubMed ID: 4612163 [No Abstract] [Full Text] [Related]
40. [The regulation of antibody formation against tumor-associated membrane antigens on primary juvenile leukemia cells during the course of the disease]. Zintl F; Plenert W; Aurich G Allerg Immunol (Leipz); 1973; 19(2-4):324-7. PubMed ID: 4281634 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]